2,5-Pyrrolidinedione, 1-(3,4-dichlorophenyl)-3-methylene-(63233-85-2)
- Name: 2,5-Pyrrolidinedione, 1-(3,4-dichlorophenyl)-3-methylene-
- Synonyms:
- Molecular Formula:C11H7Cl2NO2
- Molecular Weight:256.088
- CAS Registry Number:63233-85-2
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.63233-85-2 1-(3,4-dichlorophenyl)-3-methylenedihydro-1H-pyrrole-2,5-dione
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.63233-85-2 1-(3,4-dichlorophenyl)-3-methylenedihydro-1H-pyrrole-2,5-dione
Assay:99% Application:Fine chemical intermediates, used as the main raw material for the synthesis of various pesticides, medicines, surfactants, polymer monomers, and antifungal agents
Min. Order:0
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.63233-85-2 2,5-Pyrrolidinedione, 1-(3,4-dichlorophenyl)-3-methylene-
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:2,5-Pyrrolidinedione, 1-(3,4-dichlorophenyl)-3-methylene-
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
Other Product
- 632338-26-2/3H-1,2,4-Triazol-3-one, 4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl )-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-( 1-methylpropyl)-, rel-, monobenzenesulfonate
- 632338-27-3/1,2-Cyclopentanedicarboxamide, N-[(3,5-dichlorophenyl)methyl]-N'-[[2'-(trifluoromethyl)[1,1'-biphenyl]-4-yl] methyl]-, (1R,2R)-rel-
- 632338-28-4/3H-1,2,4-Triazol-3-one, 4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl )-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-( 1-methylpropyl)-, rel-, (2R,3R)-2,3-dihydroxybutanedioate (1:1)
- 63233-82-9/2,5-Pyrrolidinedione, 1-(3,5-dichlorophenyl)-3-[(2,6-dimethyl-4-morpholinyl)methyl]-
- 63233-83-0/2,5-Pyrrolidinedione, 1-(4-chloro-2-methylphenyl)-3-methylene-
- 632338-30-8/3H-1,2,4-Triazol-3-one, 4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl )-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-( 1-methylpropyl)-, rel-, (2S,3S)-2,3-dihydroxybutanedioate (1:1)
- 632338-31-9/1,2-Cyclopentanedicarboxamide, N-[[2'-(aminosulfonyl)[1,1'-biphenyl]-4-yl]methyl]-N'-[[2'-(trifluoromethyl)[1 ,1'-biphenyl]-4-yl]methyl]-, (1R,2R)-rel-
- 632338-37-5/1,2-Cyclopentanedicarboxamide, N,N'-dimethyl-N,N'-bis[[2'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]-, (1R,2R)-rel-
- 632338-39-7/1,2-Cyclopentanedicarboxamide, N-methyl-N'-[[4-(trifluoromethoxy)phenyl]methyl]-N-[[2'-(trifluoromethyl)[1 ,1'-biphenyl]-4-yl]methyl]-, (1R,2R)-rel-
- 632338-40-0/3H-1,2,4-Triazol-3-one,4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)-, rel-, dimethanesulfonate, compd. with 1,4-dioxane(1:1)
- 63233-84-1/2,5-Pyrrolidinedione, 3-methylene-1-(4-methyl-3-nitrophenyl)-
- 632338-42-2/3H-1,2,4-Triazol-3-one, 4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl )-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-( 1-methylpropyl)-, rel-, mono(4-methylbenzenesulfonate)
- 632338-43-3/1,2-Cyclopentanedicarboxamide, N'-([2,2'-bithiophen]-5-ylmethyl)-N-methyl-N-[(2'-methyl[1,1'-biphenyl]-4- yl)methyl]-, (1R,2R)-rel-
- 632338-46-6/1,2-Cyclohexanedicarboxamide, N-[[2'-(aminosulfonyl)[1,1'-biphenyl]-4-yl]methyl]-N'-([2,2'-bithiophen]-5-yl methyl)-, (1R,2R)-rel-
- 632338-47-7/3H-1,2,4-Triazol-3-one,4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)-, rel-, dimethanesulfonate, compd. with ethanol (1:1)
- 632338-48-8/1,2-Cyclohexanedicarboxamide, N-[[2'-(aminosulfonyl)[1,1'-biphenyl]-4-yl]methyl]-N-methyl-N'-[[4-(trifluoro methoxy)phenyl]methyl]-, (1R,2R)-rel-
- 632338-49-9/1,2-Cyclohexanedicarboxamide, N,N'-bis[[2'-(aminosulfonyl)[1,1'-biphenyl]-4-yl]methyl]-, (1R,2R)-rel-
- 632338-50-2/1,2-Cyclohexanedicarboxamide, N,N'-bis([2,2'-bithiophen]-5-ylmethyl)-, (1R,2R)-rel-
- 632338-51-3/1,2-Cyclobutanedicarboxamide, N-[[2'-(aminosulfonyl)[1,1'-biphenyl]-4-yl]methyl]-N-methyl-N'-[[4-(trifluoro methoxy)phenyl]methyl]-, (1R,2R)-rel-
- 63233-85-2/2,5-Pyrrolidinedione, 1-(3,4-dichlorophenyl)-3-methylene-
- 632338-52-4/1,2-Cyclopentanedicarboxamide, N-([2,2'-bithiophen]-5-ylmethyl)-N'-[(3,5-dichlorophenyl)methyl]-, (1R,2R)-rel-
- 632338-54-6/1,2-Cyclopentanedicarboxamide, N-[(3,5-dichlorophenyl)methyl]-N'-[[3-(difluoromethoxy)phenyl]methyl]-, (1R,2R)-rel-
- 632338-55-7/1,2-Cyclopentanedicarboxamide, N-[(3,5-dichlorophenyl)methyl]-N'-[[4-(trifluoromethyl)phenyl]methyl]-, (1R,2R)-rel-
- 632338-56-8/1,2-Cyclopentanedicarboxamide, N-[(4-chlorophenyl)methyl]-N'-[(3,5-dichlorophenyl)methyl]-, (1R,2R)-rel-
- 632338-58-0/1,2-Cyclopentanedicarboxamide, N-[(3,5-dichlorophenyl)methyl]-N'-[(3,5-dimethoxyphenyl)methyl]-, (1R,2R)-rel-
- 632338-60-4/1,2-Cyclopentanedicarboxamide, N-[(3,5-dichlorophenyl)methyl]-N'-[[4-[(methylsulfonyl)amino]phenyl]meth yl]-, (1R,2R)-rel-
- 632338-62-6/1,2-Cyclopentanedicarboxamide, N-[(3,5-dichlorophenyl)methyl]-N'-[(3-methylphenyl)methyl]-, (1R,2R)-rel-
- 632338-63-7/1,2-Cyclopentanedicarboxamide, N-[(3,5-dichlorophenyl)methyl]-N'-[[4-(trifluoromethoxy)phenyl]methyl]-, (1R,2R)-rel-
- 632338-64-8/1,2-Cyclopentanedicarboxamide, N-[(3,5-dichlorophenyl)methyl]-N'-(2-pyridinylmethyl)-, (1R,2R)-rel-
- 632338-65-9/1,2-Cyclopentanedicarboxamide, N-[(3,5-dichlorophenyl)methyl]-N'-(3-pyridinylmethyl)-, (1R,2R)-rel-